Exploration Aim: Dihexa has garnered attention in neuroscience investigation for its doable therapeutic programs in conditions involving cognitive decline, including Alzheimer’s disease.Thus, bemitil is usually a pharmacological agent of metabolic, non-exhaustive motion, which comprises cell genome activation and expression of RNA and proteins, i